Christmas Comes Early to Wingstop Fans With Gift of ‘Five

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Christmas Comes Early to Wingstop Fans With Gift of ‘Five Golden Wings’

DALLAS, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Wingstop, Inc . (NASDAQ: WING ), the award-winning wing concept with more than 900 locations worldwide, is giving fans an early gift this year, with its special “Five Golden Wings” give-away at participating U.S. restaurants.  On Wednesday, December 21, guests will receive five free boneless wings, made-to-order in the flavor of their choice, with any wing purchase made between the hours of 11 a.m. and 2 p.m., local time – partridge in a pear tree not included.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...91b8f517fe

“The holidays are all about giving and celebrating with the special people in our lives, and this holiday season, Wingstop is celebrating our fans with an early Christmas gift that’s just too good to put under any tree,” said Flynn Dekker, Chief Marketing Officer of Wingstop. “We’ve got the most loyal guests in the industry, and Five Golden Wings is our way of saying thanks and giving back to them this holiday season in the best way we know how.”

Fans can receive their five free boneless wings with any wing purchase by visiting any participating U.S. Wingstop location or placing an order via the Wingstop app, through social ordering on Facebook Messenger or Twitter, or online at order.wingstop.com and esorder.wingstop.com .

To find the perfect holiday gift for Wingstop lovers in their lives, fans are also invited to visit the Wing Shop www.WingShop.com or they can pick-up a Wingstop gift card when they’re picking up their 5 Golden Wings.

GUIDELINES & RESTRICTIONS Wingstop customers get five free boneless wings with any wing purchase.  One promotional deal per transaction. Free wings will be added to both online and in-restaurant orders automatically by our team members at the restaurant. Only valid during the hours of 11 a.m. to 2 p.m. local time on Wednesday, December 21. At participating locations only.

ABOUT WINGSTOP Founded in 1994 and headquartered in Dallas, Texas, Wingstop Inc. (NASDAQ: WING ) operates and franchises 949 restaurants across the United States, Mexico, Singapore, the Philippines, Indonesia, and the United Arab Emirates. Having grown its domestic same store sales for 12 consecutive years, the Company has been ranked #3 on the “Top 100 Fastest Growing Restaurant Chains” by Nation’s Restaurant News (2016), #7 on the “Top 40 Fast Casual Chains” by Restaurant Business (2016), and was named “Best Franchise Deal in North America” by QSR magazine (2014).  Wingstop has been designated a certified Great Place to Work® (2016), and was ranked #88 on Fortune’s 100 Best Medium Workplaces list in October 2016. The Wing Experts’ menu features classic and boneless wings with 11 bold, distinctive flavors including Original Hot, Cajun, Atomic, Mild, Teriyaki, Lemon Pepper, Hawaiian, Garlic Parmesan, Hickory Smoked BBQ, Louisiana Rub and Mango Habanero. Wingstop’s wings are always cooked to order, hand-sauced and tossed and served with a variety of house-made sides including hand-cut, seasoned fries. For more information visit www.wingstop.com or www.wingstopfranchise.com .  Follow us on facebook.com/Wingstop and Twitter @Wingstop.

MEDIA CONTACT Seth Grugle, ICR 646-277-1272 wingstop@icrinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 150

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 105

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

VIQ Solutions' Leadership Transition Marks New Era Ahead

Updated Category News Views 244

VIQ Solutions Marks a New Chapter with Leadership Changes VIQ Solutions Inc. is making noteworthy changes in its executive team that will undoubtedly shape the organization's path forward. The firm, known for being a global provider of AI-driven, secure digital voice and video capture technology, has announced the retirement of Susan Sumner, who has been a pivotal figure...

Continue Reading
Lucid Group's Fourth Quarter Success: Record Deliveries Ahead

Updated Category News Views 130

Lucid Group Inc Reports Strong Q4 Earnings Lucid Group Inc (NASDAQ: LCID) has revealed its fourth-quarter financial results, demonstrating a significant improvement in revenue and production metrics. The results were reported after the market closed on a recent Tuesday, showcasing the company's ongoing commitment to innovation in the electric vehicle sector. Revenue...

Continue Reading
Verily Sightline Collaborates with Bangor University in Europe

Updated Category News Views 149

Verily Partners with Bangor University for Wastewater Testing Verily, recognized for its precision health technology, is extending its wastewater surveillance program into Europe through a promising partnership with Bangor University. This collaboration aims to take advantage of the innovative wastewater-based public health programs at Bangor to enhance testing...

Continue Reading
Amaero's Strategic Supply Agreement Boosts U.S. Titanium Production

Updated Category News Views 213

Amaero Secures Strategic Long-Term Supply Agreement Significant Milestone in Domestic Supply Chain Development Amaero International Limited (ASX:3DA), a prominent U.S. manufacturer of high-quality titanium powders, has successfully signed a three-year Supply Agreement with The Perryman Company, a leader in titanium production. This agreement marks a pivotal moment in...

Continue Reading
NextPlat: Insights from Interim CEO on Future Directions

Updated Category News Views 132

NextPlat Corp's Interim CEO Update NextPlat Corp (NASDAQ: NXPL), a prominent player in the consumer products and services sector, recently issued a pivotal update from its interim CEO, David Phipps. This detailed letter serves as a roadmap to navigate the company’s future after the unexpected passing of its former CEO, Charles M. Fernandez. The focus is on leveraging...

Continue Reading